"The Effect of Reiki on Metabolic Parameters in Obese Type 2 Diabetes Patients''

Sponsor
Hasan Kalyoncu University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05942079
Collaborator
(none)
1
2
13.5
0.5
0

Study Details

Study Description

Brief Summary

The increase in the prevalence of diabetes and the loss of various organs and functions in the individual as a result of complications caused by diabetes affect the life expectancy and quality of individuals, and cause social and economic losses affecting the whole society. For this reason, the individual management of the diabetic patient is important in terms of ensuring effective participation and compliance in treatment and care. Patients must have knowledge, skills and positive attitudes in order to successfully comply with diabetes treatment. Patients are in compliance with diabetes treatment; they encounter some barriers such as medication barriers, barriers to self-monitoring, knowledge and belief barriers, barriers to diagnosis, barriers in relations with health professionals, barriers to lifestyle change, barriers to coping with diabetes, and barriers to getting advice and support. The American Diabetes Association (ADA) states that self-monitoring of blood sugar is important in ensuring glycemic control and preventing hyperglycemia and asymptomatic hypoglycemia. Reiki is applied as an alternative and complementary treatment method. Reiki application, when used together with pharmacological methods, chronic fatigue, diabetic neuropathy, pain caused by surgery, cancer treatment, symptoms of cardiovascular diseases, emotional disorders such as anxiety, depression, acute or chronic pain, infertility-related problems, neurodegenerative disorders, AIDS, autism and developmental disorders, Crohn's disease, irritable bowel syndrome, traumatic brain injury and has been shown to improve health problems such as fatigue.

In the literature, the effects of reiki have been examined in patient groups with different chronic diseases, but no study has been found on obese individuals with Type 2 diabetes. Therefore, reikinin in obese individuals with Type 2 diabetes; This study is planned to determine whether it has an effect on compliance with diabetes treatment, eating behaviors, anxiety levels and changes in metabolic values.

Condition or Disease Intervention/Treatment Phase
  • Other: REİKİ

Detailed Description

The increase in the prevalence of diabetes and the loss of various organs and functions in the individual as a result of complications caused by diabetes affect the life expectancy and quality of individuals, and cause social and economic losses affecting the whole society. Diabetes with poor management causes many acute and chronic complications. Keeping diabetes under control seriously affects the occurrence of microvascular and macrovascular complications, which develop over years and seriously affect life. Compliance with diabetes treatment; nutrition therapy, regular exercise program, patient self-monitoring, medication, access to health facilities and patient education. With regular monitoring and monitoring of these parameters, compliance with a successful diabetes treatment is improved. The basis of compliance with diabetes treatment is determined by the attitudes and behaviors of patients regarding their own health. For this reason, the individual management of the diabetic patient is important in terms of ensuring effective participation and compliance in treatment and care. Patients must have knowledge, skills and positive attitudes in order to successfully comply with diabetes treatment. Patients are in compliance with diabetes treatment; they encounter some barriers such as medication barriers, barriers to self-monitoring, knowledge and belief barriers, barriers to diagnosis, barriers in relations with health professionals, barriers to lifestyle change, barriers to coping with diabetes, and barriers to getting advice and support. The inability of the individual to cope with these obstacles adequately causes problems in compliance with diabetes treatment. One of the most important points in compliance with diabetes management and treatment is self-monitoring of blood glucose. The American Diabetes Association (ADA) states that self-monitoring of blood sugar is important in ensuring glycemic control and preventing hyperglycemia and asymptomatic hypoglycemia. HbA1c levels were found to be lower in patients who measured their blood glucose more frequently. In patients with poor diabetes management and persistent hyperglycemia, there is an increase in HbA1c value. A 1% increase in HbA1c value is accepted as a risk in the formation of complications. Reiki is applied as an alternative and complementary treatment method. Reiki application, when used together with pharmacological methods, chronic fatigue, diabetic neuropathy, pain caused by surgery, cancer treatment, symptoms of cardiovascular diseases, emotional disorders such as anxiety, depression, acute or chronic pain, infertility-related problems, neurodegenerative disorders, AIDS, autism and developmental disorders, Crohn's disease, irritable bowel syndrome, traumatic brain injury and has been shown to improve health problems such as fatigue (43).

In the literature, the effects of reiki have been examined in patient groups with different chronic diseases, but no study has been found on obese individuals with Type 2 diabetes. Therefore, reikinin in obese individuals with Type 2 diabetes; This study is planned to determine whether it has an effect on compliance with diabetes treatment, eating behaviors, anxiety levels and changes in metabolic values.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
1 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
The Effect of Reiki on Treatment Compliance, Eating Behaviors and Metabolic Values in Obese Individuals With Type 2 Diabetes": Randomized Controlled Study
Actual Study Start Date :
Sep 15, 2022
Anticipated Primary Completion Date :
Jul 15, 2023
Anticipated Study Completion Date :
Nov 1, 2023

Arms and Interventions

Arm Intervention/Treatment
group receiving reiki

Individuals who will undergo Reiki for 12 weeks

Other: REİKİ
Reiki is applied as an alternative and complementary treatment method.

control group

control group

Outcome Measures

Primary Outcome Measures

  1. "Reiki has a positive effect on adherence to treatment, eating behaviors and metabolic values in obese individuals with type 2 diabetes. [12 weeks]

    Metabolic changes in the patient before and after reiki

  2. Blood glucose level [12 weeks]

    HbA1c change in the patient before and after reiki

  3. Blood cholesterol level [12 weeks]

    Blood cholesterol exchange level

  4. Blood pressure [12 weeks]

    Blood pressure status

  5. Body mass index [12 weeks]

    Body mass index change

  6. Belly circumference measurement [12 weeks]

    waist circumference will be measured with a tape measure

  7. Anxiety level change [12 weeks]

    TO BE EVALUATED BY SCALE

  8. Change in eating behavior [12 weeks]

    The change in eating behavior will be evaluated with a scale

  9. Change in adherence to treatment [12 weeks]

    change in adherence to treatment will be evaluated with a scale

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Having been diagnosed with Type 2 diabetes at least 6 months ago,

  2. Body mass index ≥ 30 kg/m²

  3. Being on oral therapy or using insulin,

  4. Ability to communicate and read,

  5. Volunteering to participate in research

Exclusion Criteria:
  1. Not complying with the principle of voluntarism

  2. Answering data collection forms incompletely

  3. Desire to leave the study at any stage of the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Harran unv. Şanlıurfa Turkey
2 Harran Unv Şanlıurfa Turkey

Sponsors and Collaborators

  • Hasan Kalyoncu University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Fatmaz zehra KÜÇÜK, PHD STUDENT, Hasan Kalyoncu University
ClinicalTrials.gov Identifier:
NCT05942079
Other Study ID Numbers:
  • 2022/076
First Posted:
Jul 12, 2023
Last Update Posted:
Jul 12, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Fatmaz zehra KÜÇÜK, PHD STUDENT, Hasan Kalyoncu University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2023